Stockscreener 앱 받기
10.01
0.00%
0.00
시장 영업 전:
9.77
-0.24
-2.40%
Replimune Group Inc 주식(REPL)의 최신 뉴스
(REPL) On The My Stocks Page - news.stocktradersdaily.com
Invesco Ltd. Sells 92,952 Shares of Replimune Group, Inc. (NASDAQ:REPL) - Defense World
Perhaps timely catching Replimune Group Inc (REPL) would be a good idea - Sete News
A stock that deserves closer examination: Replimune Group Inc (REPL) - uspostnews.com
XTX Topco Ltd Purchases New Holdings in Replimune Group, Inc. (NASDAQ:REPL) - Defense World
Replimune Group, Inc. (NASDAQ:REPL) Shares Purchased by Wells Fargo & Company MN - Defense World
Potential Price Increase for Replimune Group Inc (REPL) After Recent Insider Activity - knoxdaily.com
Market Insights: Replimune Group Inc (REPL)’s Notable Gain of 2.43, Closing at 9.27 - DWinneX
Legal & General Group Plc Has $719,000 Position in Replimune Group, Inc. (NASDAQ:REPL) - Defense World
Replimune: Scope Goes Beyond That Of RP1 Oncolytic Targeting For Melanoma (NASDAQ:REPL) - Seeking Alpha
Are Replimune Group Inc’shares a good deal? - uspostnews.com
Market Momentum Report: Replimune Group Inc (REPL)’s Positive Close at 8.83 - DWinneX
A Detailed Analysis Of Replimune Group Inc (REPL) - Marketing Sentinel
Replimune Group Inc (REPL) Stock: A Year of Stock Market Ups and Downs - investchronicle.com
Wolverine World Wide, Pacira BioSciences And Other Big Stocks Moving Higher On Monday - Benzinga
Replimune Group, Inc. (NASDAQ:REPL) Shares Purchased by Geode Capital Management LLC - Defense World
JPMorgan Chase & Co. Has $5.89 Million Stock Holdings in Replimune Group, Inc. (NASDAQ:REPL) - Defense World
Alliancebernstein L.P. Sells 48,397 Shares of Replimune Group, Inc. (NASDAQ:REPL) - Defense World
Vanguard Group Inc. Has $43.55 Million Holdings in Replimune Group, Inc. (NASDAQ:REPL) - Defense World
REPL Stock Rises on FDA's Priority Review for Melanoma Drug BLA - MSN
Replimune Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | REPL Stock News - GuruFocus
Sei Investments Co. Purchases New Stake in Replimune Group, Inc. (NASDAQ:REPL) - Defense World
Replimune Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times
Replimune stock target raised to $22 at H.C. Wainwright - MSN
Navigating Uncertainty: Replimune Group’s Strategic Challenges Amid Clinical Trials and Global Risks - MSN
Is Replimune Group (NASDAQ:REPL) A Risky Investment? - simplywall.st
Replimune Group, Inc. (NASDAQ:REPL) Receives Consensus Rating of “Buy” from Analysts - Defense World
KLP Kapitalforvaltning AS Takes Position in Replimune Group, Inc. (NASDAQ:REPL) - Defense World
Corebridge Financial Inc. Reduces Position in Replimune Group, Inc. (NASDAQ:REPL) - Defense World
Replimune Group, Inc. (NASDAQ:REPL) Stake Lifted by American Century Companies Inc. - Defense World
Teacher Retirement System of Texas Takes $189,000 Position in Replimune Group, Inc. (NASDAQ:REPL) - Defense World
Replimune Group (NASDAQ:REPL) Trading Down 7.6%What's Next? - MarketBeat
SynOx Therapeutics Announces Board Chair Transition to Align with Advancing Regulatory and Commercialization Strategy - The Manila Times
Replimune Group, Inc. (NASDAQ:REPL) Shares Acquired by Swiss National Bank - Defense World
Charles Schwab Investment Management Inc. Has $6.16 Million Stake in Replimune Group, Inc. (NASDAQ:REPL) - Defense World
Victory Capital Management Inc. Purchases Shares of 44,880 Replimune Group, Inc. (NASDAQ:REPL) - Defense World
Bank of New York Mellon Corp Increases Position in Replimune Group, Inc. (NASDAQ:REPL) - Defense World
Replimune Group, Inc. (NASDAQ:REPL) Holdings Cut by AlphaQuest LLC - Defense World
Replimune Group, Inc. (NASDAQ:REPL) Receives $19.43 Average Price Target from Analysts - Defense World
Arizona State Retirement System Invests $156,000 in Replimune Group, Inc. (NASDAQ:REPL) - Defense World
Financial Metrics Check: Replimune Group Inc (REPL)’s Ratios for Trailing Twelve Months - The Dwinnex
Replimune Group Appoints New Director, Grants Stock Options By Investing.com - Investing.com Australia
Replimune Group Appoints New Director, Grants Stock Options - Investing.com
Replimune Group Appoints Michael Goller To Board, Increases Board Size To Ten -March 07, 2025 at 05:04 pm EST - Marketscreener.com
Replimune Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4) -March 07, 2025 at 04:11 pm EST - Marketscreener.com
Rhumbline Advisers Grows Position in Replimune Group, Inc. (NASDAQ:REPL) - Defense World
Replimune Raises $55 Million To Advance Its Oncolytic Immunotherapy Programs - Bain Capital
New York State Common Retirement Fund Purchases 31,231 Shares of Replimune Group, Inc. (NASDAQ:REPL) - Defense World
JPMorgan Chase & Co. Increases Replimune Group (NASDAQ:REPL) Price Target to $18.00 - MarketBeat
Replimune Group (NASDAQ:REPL) Price Target Raised to $18.00 - Defense World
Replimune Group (NASDAQ:REPL) Stock Price Up 6.1%What's Next? - MarketBeat
Replimune Group, Inc. (NASDAQ:REPL) Receives $19.29 Average Price Target from Brokerages - Defense World
0.39%
3.66%
자본화:
|
볼륨(24시간):